Elicio Therapeutics, Inc. (ELTX)
USD 4.85
(-0.21%)
USD 4.85
(-0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.69 Million | -22.17 Million | -23.93 Million | -16.7 Million | -9.29 Million | -8.02 Million |
| Net Income | -35.19 Million | -28.2 Million | -26.4 Million | -15.71 Million | -12.26 Million | -20.02 Million |
| Depreciation & Amortization | 1.17 Million | 390.31 Thousand | 251.45 Thousand | 193.43 Thousand | 108.36 Thousand | 2000.00 |
| Deferred income taxes | -927 Thousand | 947.42 Thousand | 52.96 Thousand | - | 1951.00 | - |
| Stock-based compensation | 1.17 Million | 579 Thousand | 617.75 Thousand | 304.46 Thousand | 145.08 Thousand | - |
| Change in working capital | -57 Thousand | 516.74 Thousand | 872.43 Thousand | -1.54 Million | 2.69 Million | 3.08 Million |
| Other non-cash items | 1.13 Million | 3.59 Million | 667.04 Thousand | 50.99 Thousand | 18 Thousand | 8.29 Million |
| Investing Cash Flow | -32 Thousand | -653.83 Thousand | -525.35 Thousand | -199.91 Thousand | -489.1 Thousand | - |
| Investments in PPE | -66 Thousand | -653.83 Thousand | -525.35 Thousand | -199.91 Thousand | -489.1 Thousand | - |
| Acquisitions | 34 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 34 Thousand | - | - | - | - | - |
| Financing Cash Flow | 38.61 Million | 21.2 Million | 19.39 Million | 25.06 Million | 6.29 Million | 31.74 Million |
| Debt repayment | -10 Million | - | -437.99 Thousand | -32.11 Million | -5.26 Million | -3.14 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -150 Thousand | - | - | -36 Thousand | -375 Thousand | - |
| Common Stock Issuance | 6.99 Million | 21.2 Million | 101.38 Thousand | 20.32 Million | - | 28.59 Million |
| Other Financing Activities | 21.63 Million | 21.2 Million | 19.73 Million | 25.06 Million | 6.29 Million | - |
| Accounts receivables | - | - | - | 440 Thousand | -333 Thousand | 180 Thousand |
| Accounts payables | 23 Thousand | 1.12 Million | 30.22 Thousand | 1.12 Million | -962.00 | 449 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -80 Thousand | -607.34 Thousand | 842.2 Thousand | -2.66 Million | 2.69 Million | 2.45 Million |
| Cash at beginning of period | 8.41 Million | 10.04 Million | 15.11 Million | 6.81 Million | 10.29 Million | 2.05 Million |
| Cash at end of period | 14.3 Million | 8.41 Million | 10.04 Million | 14.96 Million | 6.81 Million | 25.51 Million |
| Capital Expenditure | -66 Thousand | -653.83 Thousand | -525.35 Thousand | -199.91 Thousand | -489.1 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.88 Million | -1.63 Million | -5.07 Million | 8.15 Million | -3.48 Million | 23.45 Million |
| Free Cash Flow | -32.76 Million | -22.83 Million | -24.46 Million | -16.9 Million | -9.78 Million | -8.02 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.82 Million | -35.19 Million | -8.94 Million | -10.66 Million | -7.55 Million | -8.02 Million |
| Depreciation & Amortization | 290 Thousand | 1.17 Million | 286 Thousand | 273 Thousand | 501 Thousand | 110 Thousand |
| Deferred income taxes | - | -927 Thousand | -16 Thousand | - | - | - |
| Stock-based compensation | 324 Thousand | 1.17 Million | 337 Thousand | 339 Thousand | 279 Thousand | 224 Thousand |
| Change in working capital | -2.76 Million | -57 Thousand | -1.62 Million | 4.76 Million | -2.51 Million | -678 Thousand |
| Other non-cash items | 6.02 Million | 1.13 Million | 75 Thousand | 98 Thousand | 719 Thousand | 342 Thousand |
| Investing Cash Flow | 3000.00 | -32 Thousand | - | -45 Thousand | 30 Thousand | -17 Thousand |
| Investments in PPE | - | -66 Thousand | - | -45 Thousand | -4000.00 | -17 Thousand |
| Acquisitions | 3000.00 | 34 Thousand | - | - | 34 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3000.00 | 34 Thousand | - | - | 10 Million | -10 Million |
| Financing Cash Flow | 11.02 Million | 38.61 Million | 7 Million | 59 Thousand | 21.51 Million | 10.04 Million |
| Debt repayment | - | -10 Million | -10 Million | - | -3.26 Million | -10 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -150 Thousand | -150 Thousand | 150 Thousand | -150 Thousand | - |
| Common Stock Issuance | 5.06 Million | 6.99 Million | -2.85 Million | 9.91 Million | 67 Thousand | - |
| Other Financing Activities | 11.02 Million | 21.63 Million | 3000.00 | 59 Thousand | 31.63 Million | 40 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.26 Million | 23 Thousand | -40 Thousand | 142 Thousand | -1.46 Million | 1.38 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -67 Thousand | -80 Thousand | -1.58 Million | 4.62 Million | -929 Thousand | -507 Thousand |
| Cash at beginning of period | 14.3 Million | 8.41 Million | 17.19 Million | 22.36 Million | 10.29 Million | 8.41 Million |
| Cash at end of period | 13.2 Million | 14.3 Million | 14.3 Million | 17.19 Million | 22.36 Million | 10.29 Million |
| Capital Expenditure | - | -66 Thousand | - | -45 Thousand | -4000.00 | -17 Thousand |
| Effect of forex changes on cash | - | - | - | 2000.00 | -2000.00 | - |
| Net cash flow / Change in cash | -1.09 Million | 5.88 Million | -2.89 Million | -5.16 Million | 12.06 Million | 1.88 Million |
| Free Cash Flow | -12.12 Million | -32.76 Million | -9.89 Million | -5.22 Million | -9.47 Million | -8.15 Million |
REKO
NPKYF
MARS
TKBP
ELRRF
OILFF